Jamp Digoxin: Affected Lot May Contain Overweight Or Underweight Tablets.
JAMP Digoxin tablets in doses of 0.125 mg and 0.0625 mg are being recalled across Canada because some tablets in affected lots may weigh more or less than they should. This means tablets could contain incorrect amounts of the active ingredient, making them either less or more potent than intended. The recall affects all consumers who have received these products.
- Product
- JAMP Digoxin 0.125 MG, 0.0625MG
- Reason
- Product safety
- Classification
- Class I
- Category
- drug recall
- Country
- Canada
- Agency
- HC-DRUGS
- Recall date
- 2024-08-06
- Status
- Ongoing
- Distribution
- Canada-wide
Official recall notice from HC-DRUGS
Recall details on Nibble Recalls: https://trynibble.app/recalls/0f8ba57a-729e-4abd-bc4f-97ba953313d8